| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $59.40B | $55.75B | $49.73B |
| YoY Revenue Growth % | +6.5% | +12.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $12.17B | $10.94B | $10.65B |
| Operating Margin % | 20.5% | 19.6% | 21.4% |
| Net Income (GAAP) | $10.31B | $9.27B | $9.03B |
| EBITDA (Normalized) | $14.30B | $12.95B | $12.44B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $12.82B | $16.18B | $12.63B |
| Capital Expenditures (CapEx) | $2.67B | $2.51B | $2.24B |
| Free Cash Flow (FCF) | $10.14B | $13.67B | $10.39B |
| FCF Margin % | 17.1% | 24.5% | 20.9% |
| Return on Invested Capital (ROIC %) | 7.4% | 7.4% | 18.3% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $86.65B | $80.17B | $17.81B |
| Total Stockholders' Equity | $73.76B | $64.02B | $36.54B |